Medicare AdvantagePrior AuthMedium impact
Desmopressin Products (Revised)
Humana·Endocrinology, Internal Medicine, Family Medicine +1 more·Medicare Advantage
Effective date
Jan 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for desmopressin nasal spray and Desmoda oral solution effective January 1, 2025. Approval requires diagnosis of central diabetes insipidus and previous treatment or intolerance with generic desmopressin tablets.
Action Required
Immediately: Update prior authorization workflows to require approval before prescribing desmopressin nasal spray or Desmoda oral solution for Humana Medicare Advantage patients. Ensure documentation includes diagnosis of central diabetes insipidus and evidence of previous treatment or intolerance with generic desmopressin tablets. Claims will be denied without prior authorization.